Compare CDXS & FJET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDXS | FJET |
|---|---|---|
| Founded | 2002 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Air Freight/Delivery Services |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 256.3M | 216.9M |
| IPO Year | 2008 | N/A |
| Metric | CDXS | FJET |
|---|---|---|
| Price | $1.49 | $3.39 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 796.1K | ★ 1.2M |
| Earning Date | 05-07-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.82 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $138,590,000.00 | N/A |
| Revenue This Year | $7.73 | N/A |
| Revenue Next Year | $14.24 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 32.30 | N/A |
| 52 Week Low | $0.96 | $3.43 |
| 52 Week High | $3.87 | $28.56 |
| Indicator | CDXS | FJET |
|---|---|---|
| Relative Strength Index (RSI) | 23.79 | 32.47 |
| Support Level | $1.10 | N/A |
| Resistance Level | $1.86 | $4.95 |
| Average True Range (ATR) | 0.15 | 0.39 |
| MACD | -0.07 | -0.04 |
| Stochastic Oscillator | 5.33 | 1.26 |
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.
Starfighters Space Inc is a commercial aerospace company based at NASA's Kennedy Space Center in Florida, with an additional base of operations at Midland International Air & Space Port in Texas, and has a fleet of seven F-104 Fighter jets that are capable of flying MACH 2+. Its activities include air launch operations, pilot and space flight training, support research, hypersonic testing, and other aerospace development programs. The company has one operating segment, which is principally the operations of F-104 Fighter jets and the development of infrastructure for orbital space launch.